H.C. Wainwright Reiterates Buy Rating on Neurogene (NGNE)

March 26, 2026 6:48 AM

H.C. Wainwright analyst Mitchel Kapoor reiterated a Buy rating and $70.00 price target on Neurogene (NASDAQ: NGNE).The analyst commented: "At ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found